浏览全部资源
扫码关注微信
1.辽宁中医药大学教学实验中心,沈阳 110847
2.辽宁中医药大学实验动物中心,沈阳 110847
Published:30 December 2022,
Received:30 May 2022,
Revised:09 November 2022,
扫 描 看 全 文
陈靖,梁喜才,王健等.基于肠脑轴探讨地黄饮子对APP/PS1转基因阳性小鼠神经功能的改善作用及机制 Δ[J].中国药房,2022,33(24):2978-2984.
CHEN Jing,LIANG Xicai,WANG Jian,et al.Investigation of the improvement effect of Dihuang yinzi on neurological function of APP/PS1 double transgenic positive mice based on gut-brain axis and its mechanism[J].ZHONGGUO YAOFANG,2022,33(24):2978-2984.
陈靖,梁喜才,王健等.基于肠脑轴探讨地黄饮子对APP/PS1转基因阳性小鼠神经功能的改善作用及机制 Δ[J].中国药房,2022,33(24):2978-2984. DOI: 10.6039/j.issn.1001-0408.2022.24.07.
CHEN Jing,LIANG Xicai,WANG Jian,et al.Investigation of the improvement effect of Dihuang yinzi on neurological function of APP/PS1 double transgenic positive mice based on gut-brain axis and its mechanism[J].ZHONGGUO YAOFANG,2022,33(24):2978-2984. DOI: 10.6039/j.issn.1001-0408.2022.24.07.
目的
2
探讨地黄饮子对
APP/PS
1转基因阳性小鼠神经功能的改善作用及可能机制。
方法
2
将
APP
/
PS
1转基因阳性小鼠随机分为
APP
/
PS
1阳性模型组,地黄饮子低、中、高剂量(12、24、48 g/kg,按生药量计)组和西药组(盐酸多奈哌齐0.8 mg/kg),并以
APP
/
PS
1转基因阴性小鼠作为
APP
/
PS
1阴性正常组,每组6只。各药物组小鼠灌胃相应药液,
APP
/
PS
1阳性模型组和
APP
/
PS
1阴性正常组小鼠灌胃同体积生理盐水,每天1次,连续28 d。末次给药后,考察各组小鼠的学习和记忆能力,肠道菌群多样性(仅地黄饮子中剂量组)、海马组织神经细胞病理改变,以及Bcl-2、Bax、脑源性神经营养因子(BDNF)的表达情况。
结果
2
与
APP
/
PS
1阳性模型组比较,地黄饮子中、高剂量组小鼠的逃逸潜伏期显著缩短,穿过原平台次数显著增加(
P
<0.05)。与其余组比较,地黄饮子中剂量组的Chao1指数更低,Shannon指数更高(
P
<0.05),且其微生物菌群的操作分类单位(OTU)丰度有所降低,优势菌种为梭菌纲
o_Clostridia
_vadinBB60_group、疣微菌
g_UCG_
005。与
APP
/
PS
1阳性模型组比较,地黄饮子中、高剂量组小鼠海马CA1区神经细胞病理改变有所改善,其海马组织中Bcl-2、BDNF蛋白的表达均显著上调,Bax蛋白的表达均显著下调(
P
<0.05)。
结论
2
地黄饮子可增强肠道菌群多样性,改变优势菌种,并能抑制大脑神经细胞凋亡,提高BDNF水平;其作用机制可能是借助肠脑轴来保护神经细胞,从而提高
APP
/
PS
1阳性模型小鼠的学习和认知能力。
OBJECTIVE
2
To investigate the improvement effect of Dihuang yinzi on neurological function of
APP
/
PS
1 double transgenic positive mice and its possible mechanism.
METHODS
2
APP
/
PS
1 double transgenic positive mice were randomly divided into
APP
/
PS
1 positive model group, Dihuang yinzi low-dose, medium-dose and high-dose groups (12, 24, 48 g/kg,by the amount of crude drug), western medicine group (donepezil hydrochloride 0.8 mg/kg);
APP
/
PS
1 transgenic negative mice were included in as
APP
/
PS
1 negative normal group, with 6 mice in each group. Administration groups were given relevant medicine intragastrically;
APP
/
PS
1 positive model group and
APP
/
PS
1 negative normal group were given constant volume of normal saline intragastrically, once a day, for consecutive 28 d. After the last medication, the ability of learning and memory, intestinal flora diversity (only medium-dose group of Dihuang yinzi), pathological changes of neural cells in hippocampus, and the expressions of Bcl-2, Bax and brain-derived neurotrophic factor (BDNF) in mice of each group were investigated.
RESULTS
2
Compared with
APP
/
PS
1 positive model group, escape latency of mice was shortened significantly in Dihuang yinzi medium-dose and high-dose groups, while the times of crossing the platform significantly increased (
P
<0.05). Compared with
APP
/
PS
1 positive model group, Chao1 index of Dihuang yinzi medium-dose group was lower, while Shannon index was higher (
P
<0.05); OTU abundance of microbial flora was decreased to some extent; dominant flora was Clostridia
o
_
Clostridia
_ vadinBB60_ Group, verruca
G
_
UCG
_005. Compared with the
APP
/
PS
1 positive model group, the pathological changes of the nerve cells in the hippocampal CA1 area of mice were improved in the medium-dose and high-dose groups of Dihuang yinzi; the protein expressions of Bcl-2 and BDNF in the hippocampal tissue were significantly increased, while the protein expression of Bax was significantly decreased (
P
<0.05).
CONCLUSIONS
2
Dihuang yinzi can enhance the diversity of flora, change the type of dominant flora, and can inhibit the apoptosis of brain neurons, and increase the level of BDNF; its mechanism may be to protect nerve cells by means of gut-brain axis, thereby improving the learning and memory ability of
APP
/
PS
1 positive model mice.
地黄饮子肠脑轴神经功能学习记忆能力APP/PS1转基因阳性小鼠
gut-brain axisneurological functionlearning and memory abilityAPP/PS1 double transgenic positive mice
金衔,陈吉聪,辛玉英,等. 参枣健脑口服液对阿尔茨海默病模型小鼠的神经保护作用及机制[J]. 中国药房,2022,33(7):836-841,847.
许青,赵晓芹,刘彦君,等. 基于“心与小肠相表里”探讨回肠菌群在七圣丸抗阿尔茨海默病中的变化[J]. 中国实验方剂学杂志,2022,28(4):9-18.
王洋,赵福红,宫铭海,等. 蛋白质组学在阿尔茨海默病早期诊断及中医药防治中的研究进展[J]. 中国实验方剂学杂志,2021,27(16):227-236.
KIM D,WANG R D,KISS A,et al. Depression and increased risk of Alzheimer’s dementia:longitudinal analyses of modifiable risk and sex-related factors[J]. Am J Geriatr Psychiatry,2021,29(9):917-926.
陈靖,韩兆丰,付彦君,等. 经方小柴胡汤化裁方对阿尔茨海默病小鼠海马组织细胞炎性因子IL-1β、IL-6及p-p38 MARK、NF-κB表达水平的影响[J]. 中华中医药学刊,2020,38(12):217-220,299.
李全,贾斯婷,关慧波. 地黄饮子辅助治疗肾虚髓减型2型糖尿病合并轻度认知功能障碍的临床疗效观察[J]. 时珍国医国药,2022,33(2):410-412.
姬令山,秦合伟,王改风,等. 地黄饮子通过调控miR-34a-5p影响细胞凋亡及炎性反应治疗阿尔茨海默病的机制[J]. 北京中医药大学学报,2022,45(1):53-61.
QIAN X H,SONG X X,LIU X L,et al. Inflammatory pathways in Alzheimer’s disease mediated by gut microbiota[J]. Ageing Res Rev,2021,68:101317.
NIKOLOVA V L,SMITH M R B,HALL L J,et al. Perturbations in gut microbiota composition in psychiatric disorders:a review and meta-analysis[J]. JAMA Psychiatry,2021,78(12):1343-1354.
邓敏贞,钟晓琴,彭丽霖,等. 阿尔茨海默病的病理机制及中医药防治机制研究进展[J]. 广州中医药大学学报,2022,39(4):984-990.
刘兵,李冬梅,张颖. 多奈哌齐与尼莫地平联合治疗血管性痴呆的疗效[J]. 中国老年学杂志,2020,40(15):3279-3281.
张雷,范占芳,张作鹏,等. 阿尔兹海默症发病机制及相关治疗药物的研究进展[J]. 中国药物化学杂志,2021,31(6):438-446,469.
赵烊烊,范兴丽,王晓翔,等. 肠道菌群失调与中枢神经系统性疾病研究进展[J]. 实用中医内科杂志,2020,34(12):64-68.
CHIDAMBARAM S B,ESSA M M,RATHIPRIYA A G,et al. Gut dysbiosis,defective autophagy and altered immune responses in neurodegenerative diseases:tales of a vicious cycle[J]. Pharmacol Ther,2022,231:107988.
GASALY N,HERMOSO M A,GOTTELAND M. Buty- rate and the fine-tuning of colonic homeostasis:implication for inflammatory bowel diseases[J]. Int J Mol Sci,2021,22(6):3061.
YANG B B,WEI J B,JU P J,et al. Effects of regulating intestinal microbiota on anxiety symptoms:a systematic review[J]. Gen Psychiatr,2019,32(2):e100056.
ZHU G S,ZHAO J X,ZHANG H,et al. Administration of Bifidobacterium breve improves the brain function of Aβ1-42-treated mice via the modulation of the gut micro- biome[J]. Nutrients,2021,13(5):1602.
REVI M. Alzheimer’s disease therapeutic approaches[J]. Adv Exp Med Biol,2020,1195:105-116.
VENKATESAN R S,SADIQ A M M. Effect of morin-5′- sulfonic acid sodium salt on the expression of apoptosis related proteins caspase 3,Bax and Bcl 2 due to the mercury induced oxidative stress in albino rats[J]. Biomed Pharmacother,2017,85:202-208.
MAHESHWARI R,SCHLUTER M,PEPIN D,et al. Abstract 4319:analysis of Bcl-2 family members and protein-protein interactions using novel multiplex immunoassays[J]. Cancer Res,2017,77(13_Supplement):4319.
黄汉陵,李阳. 复发性流产患者阴道菌群变化及其与凋亡蛋白Bcl-2和Bax的相关性[J]. 中国微生态学杂志,2022,34(2):216-219.
CUTULI D,LANDOLFO E,PETROSINI L,et al. Environmental enrichment effects on the brain-derived neurotrophic factor expression in healthy condition,Alzheimer’s disease,and other neurodegenerative disorders[J]. J Alzheimers Dis,2022,85(3):975-992.
张誉丹.基于“肠-脑轴”理论探讨固本健脑液调控Aβ沉积防治AD的作用机制[D]. 武汉:湖北中医药大学,2021.
魏海军,肖凡. BDNF/TrkB通路对硫化氢减轻同型半胱氨酸诱导大鼠海马神经元凋亡的影响[J]. 中国现代医生,2022,60(2):34-36,40,197.
0
Views
1
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution